Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases ...
The trial met both primary endpoints, with tirzepatide showing a 38% decrease in heart failure outcomes compared to placebo.
Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma ...
SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback